Artificial Intelligence In Diabetes Management Market Size, Share & Trends Analysis Report By Generic Drug (Glasdegib, Sonidegib, Vismodegib), By Dosage (Capsule and Injection), By End User (Homecare, Hospitals, Specialty Clinics), By Region, And By Segment Forecasts, 2025-2034
Global Artificial Intelligence In Diabetes Management Market is valued at USD 13.8 Bn in 2024 and is predicted to reach USD 32.4 Bn by the year 2034 at a 10.6% CAGR during the forecast period for 2025-2034.
Artificial intelligence in diabetes management describes medical devices that observe, analyze, and treat diabetes remotely. The biological condition known as diabetes raises sugar levels in the circulatory system. The digital treatment of diabetes includes utilising software-driven systems, apps, and gadgets, including injection pens, detectors, closed-loop techniques, insulin updates, and smart glucose meters. This absorbed strategy addresses the difficulty of managing diabetes in a population that is becoming more and more common by facilitating better choice-making and treatment coordination.
The demand for diabetes management platforms is growing significantly due to technological improvements. The industry for diabetes management platforms is expanding as a result of the growing emphasis on individualized therapy. The requirement for platforms that provide individualized solutions is being driven by patients' growing need for therapies that are specifically designed to meet their demands.
However, one of the biggest issues when using AI to control diabetes is data security and privacy. In medical treatment, artificial intelligence relies significantly on tailored patient data, such as lifestyle characteristics, genealogy data, and private health records. For AI systems to produce precise forecasts and treatment suggestions, this type of data must be gathered and analyzed. However, because this data is so sensitive, it is vulnerable to cyberattacks and breaches, which might seriously jeopardize patient privacy. Additionally, worries regarding patient data privacy and a lack of knowledge about digital diabetes treatment are impeding market expansion in underdeveloped nations.
Some major key players in the artificial intelligence in diabetes management market:
- Vodafone Group PLC
- Apple Inc
- Google Inc
- International Business Machines Corporation (IBM)
- Glooko Inc
- Tidepool Inc
Market Segmentation:
The artificial intelligence in diabetes management market is segmented based on device and technique. Based on the device, the market is segmented into diagnostic devices, glucose monitoring devices, and insulin delivery devices. By technique, the market is segmented into case-based reasoning and intelligent data analysis.
Based on the Device, the Insulin Delivery Devices Segment is Accounted as a Major Contributor to the Artificial Intelligence in Diabetes Management Market
Insulin delivery devices are expected to hold a major global market share in 2021 in the artificial intelligence in diabetes management market. These devices provide accurate insulin administration, lowering the chance of bradycardia and enhancing glucose regulation in general. More patients choose robots over manual techniques as insulin delivery system technology improves and becomes highly accessible and efficient. The use of intelligent insulin delivery systems is being further accelerated by their progress, which integrates with online resources for remote oversight and analysis.
Intelligent Data Analysis Segment to Witness Growth at a Rapid Rate
The intelligent data analysis segment is growing in the artificial intelligence market for diabetes management because diabetic individuals create so much data—including lifestyle information, medical records, and glucose levels—that it takes sophisticated analytical methods to glean helpful insights. Additionally, as AI algorithms and machine learning methods progress, data analysis becomes more precise and effective, propelling intelligent data analysis systems in diabetes management.
In The Region, The North American Artificial Intelligence In Diabetes Management Market Holds A Significant Revenue Share
The North American artificial intelligence in the diabetes management market is expected to register the highest market share in revenue shortly. This can be attributed to the region's established leading companies and the rising incidence of diabetes. Another factor contributing to the region's dominance in this sector is the existence of reputable artificial intelligence firms. Due to the combination of these variables, North America is leading the worldwide demand for artificial intelligence in diabetes management. In addition, the Asia Pacific is expected to grow rapidly in the artificial intelligence in diabetes management market owing to an increasing proportion of people with the disease, rising medical expenses, and more knowledge about how to treat the disease. Furthermore, government programs that encourage diabetes control, increased financial resources, and improved medical facilities contribute to the market's acceleration.
Competitive Landscape
The key players in the artificial intelligence in diabetes management market have shifted their focus toward technological advancement and higher demand for them. They are initiating significant strategies, such as mergers and joint ventures of major and domestic players, to expand their selection of products and raise their global market footprint. Some of the major key players in the artificial intelligence in diabetes management market are Vodafone Group PLC, Apple Inc, Google Inc, International Business Machines Corporation (IBM), Glooko Inc, and Tidepool Inc.
Artificial Intelligence In Diabetes Management Market Report Scope:
| Report Attribute | Specifications |
| Market Size Value In 2024 | USD 13.8 Billion |
| Revenue Forecast In 2034 | USD 32.4 Billion |
| Growth Rate CAGR | CAGR of 10.6% from 2025 to 2034 |
| Quantitative Units | Representation of revenue in US$ Mn,and CAGR from 2025 to 2034 |
| Historic Year | 2021 to 2024 |
| Forecast Year | 2025-2034 |
| Report Coverage | The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
| Segments Covered | By Device, Technique |
| Regional Scope | North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
| Country Scope | U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; France; Italy; Spain; South East Asia; South Korea |
| Competitive Landscape | Vodafone Group PLC, Apple Inc, Google Inc, International Business Machines Corporation (IBM), Glooko Inc, and Tidepool Inc. |
| Customization Scope | Free customization report with the procurement of the report and modifications to the regional and segment scope. Particular Geographic competitive landscape. |
| Pricing And Available Payment Methods | Explore pricing alternatives that are customized to your particular study requirements. |
Segmentation of Artificial Intelligence in Diabetes Management Market -
By Device
- Diagnostic Devices
- Glucose Monitoring Devices
- Insulin Delivery Devices
By Technique
- Case-Based Reasoning
- Intelligent Data Analysis
By Region-
North America-
- The US
- Canada
- Mexico
Europe-
- Germany
- The UK
- France
- Italy
- Spain
- Rest of Europe
Asia-Pacific-
- China
- Japan
- India
- South Korea
- South East Asia
- Rest of Asia Pacific
Latin America-
- Brazil
- Argentina
- Rest of Latin America
Middle East & Africa-
- GCC Countries
- South Africa
- Rest of the Middle East and Africa
Research Design and Approach
This study employed a multi-step, mixed-method research approach that integrates:
- Secondary research
- Primary research
- Data triangulation
- Hybrid top-down and bottom-up modelling
- Forecasting and scenario analysis
This approach ensures a balanced and validated understanding of both macro- and micro-level market factors influencing the market.
Secondary Research
Secondary research for this study involved the collection, review, and analysis of publicly available and paid data sources to build the initial fact base, understand historical market behaviour, identify data gaps, and refine the hypotheses for primary research.
Sources Consulted
Secondary data for the market study was gathered from multiple credible sources, including:
- Government databases, regulatory bodies, and public institutions
- International organizations (WHO, OECD, IMF, World Bank, etc.)
- Commercial and paid databases
- Industry associations, trade publications, and technical journals
- Company annual reports, investor presentations, press releases, and SEC filings
- Academic research papers, patents, and scientific literature
- Previous market research publications and syndicated reports
These sources were used to compile historical data, market volumes/prices, industry trends, technological developments, and competitive insights.
Primary Research
Primary research was conducted to validate secondary data, understand real-time market dynamics, capture price points and adoption trends, and verify the assumptions used in the market modelling.
Stakeholders Interviewed
Primary interviews for this study involved:
- Manufacturers and suppliers in the market value chain
- Distributors, channel partners, and integrators
- End-users / customers (e.g., hospitals, labs, enterprises, consumers, etc., depending on the market)
- Industry experts, technology specialists, consultants, and regulatory professionals
- Senior executives (CEOs, CTOs, VPs, Directors) and product managers
Interview Process
Interviews were conducted via:
- Structured and semi-structured questionnaires
- Telephonic and video interactions
- Email correspondences
- Expert consultation sessions
Primary insights were incorporated into demand modelling, pricing analysis, technology evaluation, and market share estimation.
Data Processing, Normalization, and Validation
All collected data were processed and normalized to ensure consistency and comparability across regions and time frames.
The data validation process included:
- Standardization of units (currency conversions, volume units, inflation adjustments)
- Cross-verification of data points across multiple secondary sources
- Normalization of inconsistent datasets
- Identification and resolution of data gaps
- Outlier detection and removal through algorithmic and manual checks
- Plausibility and coherence checks across segments and geographies
This ensured that the dataset used for modelling was clean, robust, and reliable.
Market Size Estimation and Data Triangulation
Bottom-Up Approach
The bottom-up approach involved aggregating segment-level data, such as:
- Company revenues
- Product-level sales
- Installed base/usage volumes
- Adoption and penetration rates
- Pricing analysis
This method was primarily used when detailed micro-level market data were available.
Top-Down Approach
The top-down approach used macro-level indicators:
- Parent market benchmarks
- Global/regional industry trends
- Economic indicators (GDP, demographics, spending patterns)
- Penetration and usage ratios
This approach was used for segments where granular data were limited or inconsistent.
Hybrid Triangulation Approach
To ensure accuracy, a triangulated hybrid model was used. This included:
- Reconciling top-down and bottom-up estimates
- Cross-checking revenues, volumes, and pricing assumptions
- Incorporating expert insights to validate segment splits and adoption rates
This multi-angle validation yielded the final market size.
Forecasting Framework and Scenario Modelling
Market forecasts were developed using a combination of time-series modelling, adoption curve analysis, and driver-based forecasting tools.
Forecasting Methods
- Time-series modelling
- S-curve and diffusion models (for emerging technologies)
- Driver-based forecasting (GDP, disposable income, adoption rates, regulatory changes)
- Price elasticity models
- Market maturity and lifecycle-based projections
Scenario Analysis
Given inherent uncertainties, three scenarios were constructed:
- Base-Case Scenario: Expected trajectory under current conditions
- Optimistic Scenario: High adoption, favourable regulation, strong economic tailwinds
- Conservative Scenario: Slow adoption, regulatory delays, economic constraints
Sensitivity testing was conducted on key variables, including pricing, demand elasticity, and regional adoption.
Request Customization
Add countries, segments, company profiles, or extend forecast — free 10% customization with purchase.
Customize This Report →Enquire Before Buying
Speak with our analyst team about scope, methodology, pricing, or deliverable formats.
Enquire Now →Frequently Asked Questions
Artificial Intelligence In Diabetes Management Market is valued at USD 13.8 Bn in 2024 and is predicted to reach USD 32.4 Bn by the year 2034
Artificial Intelligence In Diabetes Management Market is expected to grow at a 10.6% CAGR during the forecast period for 2025-2034
Vodafone Group PLC, Apple Inc, Google Inc, International Business Machines Corporation (IBM), Glooko Inc, and Tidepool Inc
Device and Technique are the key segments of the Artificial Intelligence In Diabetes Management Market.
North America region is leading the Artificial Intelligence In Diabetes Management Market.